This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gilupi Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovations of Oliver Harnack in Prenatal Diagnostics
Introduction
Oliver Harnack is an inventive mind based in Potsdam OT Golm, Germany. He has made significant strides in the field of diagnostic devices, particularly focusing on prenatal diagnostics. With his expertise, he seeks to enhance the safety and efficiency of detecting analytes, which are crucial in prenatal care.
Latest Patents
Harnack holds a patent for a groundbreaking invention titled "Diagnostic analyte collection device based on flexible polymers with biological surface modification and microfluidic functionality." This innovative device aims to provide alternative prenatal diagnostic methods that mitigate the risks associated with current practices. The device features a polymer fiber integrated with capturing molecules that bind to specific analytes and linker molecules, enhancing the detection process.
Career Highlights
Oliver Harnack currently works at Gilupi GmbH, a company renowned for its commitment to advancing medical diagnostics. His contributions to the field exemplify the intersection of technology and healthcare, aiming to improve patient outcomes through innovative solutions.
Collaborations
Throughout his career, Harnack has collaborated with notable colleagues, including Klaus Lücke and Ekkehardt Weber. These partnerships are integral to the development and refinement of his invention, showcasing the collaborative spirit that drives innovation in technology and diagnostics.
Conclusion
Oliver Harnack's work represents a significant advancement in prenatal diagnostics, demonstrating the potential of innovative devices in healthcare. His patent highlights the importance of developing safer and more effective methods for detecting analytes, ultimately contributing to better outcomes for expectant mothers and their children.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile